Arginine Metabolism in Pediatric Type 2 Diabetes (ARMET Study) (H-51936)
Description
Content
This study aims to investigate arginine metabolism and the effect of arginine administration in children with type 2 diabetes compared to healthy controls.
Eligibility Criteria: 12 to 17-year-old healthy children and children with type 2 diabetes
Investigators: Mustafa Tosur, M.D. (principal investigator), Maria J. Redondo M.D., Ph.D.(co-investigator), Jean Hsu, PhD (co-investigator), Ashok Balasubramanyam (co-investigator)
Supported by: NIH K23 Award
Contact
Phone 1: 832–822–3787
IRB: H-51936
Status:
Active
Created:
